Current concepts in the management of rheumatoid arthritis
Yoshiya Tanaka
Korean J Intern Med. 2016;31(2):210-218.   Published online 2016 Feb 26     DOI: https://doi.org/10.3904/kjim.2015.137
Citations to this article as recorded by Crossref logo
Anti-rheumatoid arthritis potential of different fractions derived from of Coluria longifolia
Yan-ping Gao, Qiuting Ma, Jian Liang, Qiang Wu, Yu-ye Zhu, Xi-de Ye, Zhiyong Liu
Heliyon.2024; 10(1): e23893.     CrossRef
Niosomal-based Drug Delivery System: A Novel Target Strategy for the Treatment of Arthritis
Priyanka A. Mandal, Nilakshi N. Dhoble, Nitin Padole, Pankaj Dhapke, Jagdish R. Baheti
Asian Journal of Research in Pharmaceutical Sciences.2024; : 139.     CrossRef
A retrospective, longitudinal study of rheumatoid arthritis treatment patterns with Janus kinase inhibitors and other disease-modifying antirheumatic drugs in Japan
Yuko Kaneko, Masaya Sakurai, Robert Snijder, Satoshi Kokubo, Daisuke Kato
Modern Rheumatology.2023; 33(3): 448.     CrossRef
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate
Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, Toshihiro Nanki, Hisanori Umehara, Nobuyuki Yasuda, Fumitoshi Tago, Yasumi Kitahara, Makoto Kawakubo, Kentaro Torii, Seiichiro Hojo, Tetsu Kawano, Toshio Imai
Modern Rheumatology.2023; 34(1): 37.     CrossRef
Effectiveness of Dynamic Metacarpophalangeal Splint in Treatment of Ulnar Deviation of Rheumatoid Arthritis on Pinch Strength and Functional Ability in Women
Rohina Kumari, Sakshi Saharawat
JPO Journal of Prosthetics and Orthotics.2023; 35(4): 266.     CrossRef
Wnt5a: A promising therapeutic target for inflammation, especially rheumatoid arthritis
Yurong Huang, Qiuyun Xue, Jun Chang, Xiao Wang, Chenggui Miao
Cytokine.2023; 172: 156381.     CrossRef
Rheumatoid arthritis: the old issue, the new therapeutic approach
Mahnaz Babaahmadi, Behnoosh Tayebi, Nima Makvand Gholipour, Mehrnaz Tayebi Kamardi, Sahel Heidari, Hossein Baharvand, Mohamadreza Baghaban Eslaminejad, Ensiyeh Hajizadeh-Saffar, Seyedeh-Nafiseh Hassani
Stem Cell Research & Therapy.2023;[Epub]     CrossRef
Tofacitinib Citrate-loaded Nanoparticle Gel for the Treatment of Alopecia Areata: Response Surface Design, Formulation and In vitro-in Vivo Characterization
Mounika Kuchukuntla, Venkatesan Palanivel, Ananthula Madhubabu
Recent Advances in Drug Delivery and Formulation.2023; 17(4): 314.     CrossRef
PROSPECTS FOR INNOVATIVE DRUGS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
A. Romanycheva, M. Korsakov, M. Dorogov, V. Fedorov, A. Shetnev, A. Arshinov
Problems of Biological, Medical and Pharmaceutical Chemistry.2023; : 55.     CrossRef
Unraveling the Molecular Mechanism of Recognition of Selected Next-Generation Antirheumatoid Arthritis Inhibitors by Janus Kinase 1
Md Fulbabu Sk, Nisha Amarnath Jonniya, Rajarshi Roy, Parimal Kar
ACS Omega.2022; 7(7): 6195.     CrossRef
Fasciola hepatica extract suppresses fibroblast-like synoviocytes in vitro and alleviates experimental arthritis
Suelen Pizzolatto Dalmolin, Renata Ternus Pedó, Thales Hein da Rosa, Jordana Miranda de Souza Silva, Mirian Farinon, Maria Luísa Gasparini, Eduardo Cremonese Filippi Chiela, Ana Helena Paz, Martín Pablo Cancela Sehabiague, Henrique Bunselmeyer Ferreira, R
Advances in Rheumatology.2022;[Epub]     CrossRef
A Review on Rheumatoid Arthritis Interventions and Current Developments
Nikita Khanna, Anil Kumar, Sandip V. Pawar
Current Drug Targets.2021; 22(4): 463.     CrossRef
A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs
Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, Toshihiro Nanki, Hisanori Umehara, Nobuyuki Yasuda, Fumitoshi Tago, Yasumi Kitahara, Makoto Kawakubo, Kentaro Torii, Seiichiro Hojo, Tetsu Kawano, Toshio Imai
Modern Rheumatology.2021; 31(4): 783.     CrossRef
Romatoid artrit - tedavi prensipleri: Ne zaman geçiş yapalım?
Didem ARSLAN
Ege Tıp Dergisi.2021; : 36.     CrossRef
Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study
Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, Toshihiro Nanki, Hisanori Umehara, Nobuyuki Yasuda, Fumitoshi Tago, Yasumi Kitahara, Makoto Kawakubo, Kentaro Torii, Seiichiro Hojo, Tetsu Kawano, Toshio Imai
Arthritis & Rheumatology.2021; 73(4): 587.     CrossRef
Fusion proteins of biologic agents in the treatment of rheumatoid arthritis (RA)
Mingcai Wu, Mengjun Tao, Quanhai Wang, Xiaohua Lu, Hui Yuan
Medicine.2021; 100(24): e26350.     CrossRef
Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
Lukas Schlager, Michaela Loiskandl, Daniel Aletaha, Helga Radner
Rheumatology.2020; 59(2): 324.     CrossRef
Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients
Niveditha Muralidharan, Rajan Sundaram, Sunitha Kodidela, K. G. Chengappa, Christina Mary Mariaselvam, Durga P. Misra, Vir S. Negi
The Pharmacogenomics Journal.2020; 20(2): 342.     CrossRef
Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study
Sae Ochi, Kazuyoshi Saito, Fumitaka Mizoguchi, Shigeaki Kato, Yoshiya Tanaka
Arthritis Research & Therapy.2020;[Epub]     CrossRef
The Management of Perioperative Immunosuppressant Medications for Rheumatoid Arthritis During Elective Hand Surgery
Kevin M. Klifto, Brian H. Cho, Scott D. Lifchez
The Journal of Hand Surgery.2020; 45(8): 779.e1.     CrossRef
JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis
Sanjiv Singh, Shantanu Singh
International Immunopharmacology.2020; 86: 106731.     CrossRef
Treatment strategy for patients with rheumatoid arthritis
Soo-Kyung Cho, Yoon-Kyoung Sung
Journal of the Korean Medical Association.2020; 63(7): 422.     CrossRef
Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects
Wonsuk Shin, A-Young Yang, Hyeonji Yun, Doo-Yeoun Cho, Kyung Hee Park, Hyunju Shin, Anhye Kim
Translational and Clinical Pharmacology.2020; 28(3): 160.     CrossRef

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases

Yoshiya Tanaka, Kana Hoshino-Negishi, Yoshikazu Kuboi, Fumitoshi Tago, Nobuyuki Yasuda, Toshio Imai
ImmunoTargets and Therapy.2020; Volume 9: 241.     CrossRef
The economic burden of depression among adults with rheumatoid arthritis in the United States
Nan Li, Edmond Chan, Steve Peterson
Journal of Medical Economics.2019; 22(4): 372.     CrossRef
Novel aspects of the activation of NADPH oxidase in neutrophils of rheumatic patients on biological therapy
Viera Jančinová, Katarína Drábiková, Zdenko Killinger, Silvia Pažoureková, Radomír Nosáľ, Juraj Payer
International Immunopharmacology.2019; 69: 368.     CrossRef
Tofacitinib is a modern solution to the problem of resistant rheumatoid arthritis
I. V. Menshikova, V. V. Strogonova
Modern Rheumatology Journal.2019; 13(2): 80.     CrossRef
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations
Iain B. McInnes, Nicole L. Byers, Richard E. Higgs, Jonathan Lee, William L. Macias, Songqing Na, Robert A. Ortmann, Guilherme Rocha, Terence P. Rooney, Thomas Wehrman, Xin Zhang, Steven H. Zuckerman, Peter C. Taylor
Arthritis Research & Therapy.2019;[Epub]     CrossRef
Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study
Yoshiya Tanaka, Kiyotaka Yamazaki, Ryo Nakajima, Shuichi Komatsu, Ataru Igarashi, Toshiro Tango, Tsutomu Takeuchi
Modern Rheumatology.2018; 28(1): 39.     CrossRef
Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients
Niveditha Muralidharan, Reena Gulati, Durga Prasanna Misra, Vir S. Negi
Clinical and Experimental Medicine.2018; 18(1): 101.     CrossRef
A Novel Mobile App and Population Management System to Manage Rheumatoid Arthritis Flares: Protocol for a Randomized Controlled Trial
Penny Wang, Dee Luo, Fengxin Lu, Josephine S Elias, Adam B Landman, Kaleb D Michaud, Yvonne C Lee
JMIR Research Protocols.2018; 7(4): e84.     CrossRef
Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system
Yoshiya Tanaka, Takeshi Ohira
Current Opinion in Pharmacology.2018; 40: 110.     CrossRef
Gum Arabic Fibers Decreased Inflammatory Markers and Disease Severity Score among Rheumatoid Arthritis Patients, Phase II Trial
Ebtihal Kamal, Lamis AbdelGadir Kaddam, Maha Dahawi, Montaser Osman, Mohammed Abdelraman Salih, Alnour Alagib, Amal Saeed
International Journal of Rheumatology.2018; 2018: 1.     CrossRef
Fengshi Gutong Capsule Attenuates Osteoarthritis by Inhibiting MAPK, NF-κB, AP-1, and Akt Pathways
Yao-Xin Gao, Hao-Heng Yu, Chuan He, Ming Li, Dan-Dan Guo, Jun-Jiang Lian, Hai-Jie Yang, Mian Wang, Lei Wang, Zhi-Wei Feng, Bin-Feng Cheng
Frontiers in Pharmacology.2018;[Epub]     CrossRef
Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights
Kumar Janakiraman, Venkateshwaran Krishnaswami, Vijaya Rajendran, Subramanian Natesan, Ruckmani Kandasamy
Materials Today Communications.2018; 17: 200.     CrossRef
Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis
Yoshiya Tanaka, Iain B. McInnes, Peter C. Taylor, Nicole L. Byers, Lei Chen, Stephanie de Bono, Maher Issa, William L. Macias, Veronica Rogai, Terence P. Rooney, Douglas E. Schlichting, Steven H. Zuckerman, Paul Emery
Arthritis & Rheumatology.2018; 70(12): 1923.     CrossRef
CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study
Philip J. Mease, Slawomir Jeka, Juan Jose Jaller, Tasanee Kitumnuaypong, Worawit Louthrenoo, Herman Mann, Galina Matsievskaia, Enrique R. Soriano, Bin Jia, Caihong Wang, Jing Nie, Elizabeth Hsia
The Journal of Rheumatology.2018; 45(1): 22.     CrossRef
Integrating Network Pharmacology and Metabolomics Study on Anti-rheumatic Mechanisms and Antagonistic Effects Against Methotrexate-Induced Toxicity of Qing-Luo-Yin
Jian Zuo, Xin Wang, Yang Liu, Jing Ye, Qingfei Liu, Yan Li, Shao Li
Frontiers in Pharmacology.2018;[Epub]     CrossRef
Rheumatoid Arthritis: A Novel Approach in Diagnosis and Treatment
Marina Kostic
Serbian Journal of Experimental and Clinical Research.2018;[Epub]     CrossRef
Vitamin D Deficiency and Rheumatoid Arthritis
Larissa Lumi Watanabe Ishikawa, Priscila Maria Colavite, Thais Fernanda de Campos Fraga-Silva, Luiza Ayumi Nishiyama Mimura, Thais Graziela Donegá França, Sofia Fernanda Gonçalves Zorzella-Pezavento, Fernanda Chiuso-Minicucci, Larissa Doddi Marcolino, Mar
Clinical Reviews in Allergy & Immunology.2017; 52(3): 373.     CrossRef
Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study
Tsutomu Takeuchi, Ryo Nakajima, Shuichi Komatsu, Kiyotaka Yamazaki, Tomohiro Nakamura, Naoki Agata, Ataru Igarashi, Toshiro Tango, Yoshiya Tanaka
Advances in Therapy.2017; 34(3): 686.     CrossRef
Effects of antirheumatic drug underutilization on rheumatoid arthritis disease activity
Mohammad A. Y. Alqudah, Sayer Al-azzam, Karem Alzoubi, Mohammad Alkhatatbeh, Khaldoon Alawneh, Ola Alazzeh, Bayan Ababneh
Inflammopharmacology.2017; 25(4): 431.     CrossRef
Pharmacologic treatment of rheumatoid arthritis
Soo-Kyung Cho, Sang-Cheol Bae
Journal of the Korean Medical Association.2017; 60(2): 156.     CrossRef
Liquiritin, a flavone compound from licorice, inhibits IL-1β-induced inflammatory responses in SW982 human synovial cells
Yao-Xin Gao, Bin-Feng Cheng, Jun-Jiang Lian, Dan-Dan Guo, Jing-Wen Qin, Yong-Bo Zhang, Hai-Jie Yang, Mian Wang, Lei Wang, Zhi-Wei Feng
Journal of Functional Foods.2017; 33: 142.     CrossRef
Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia
Marina Kostic
Serbian Journal of Experimental and Clinical Research.2017; 18(4): 343.     CrossRef
Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis
Kyoung-Woon Kim, Bo-Mi Kim, Kyung-Ann Lee, Sang-Heon Lee, Gary S. Firestein, Hae-Rim Kim
Scientific Reports.2017;[Epub]     CrossRef
Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist’s point of view
So-My Koo, Soo-Taek Uh
The Korean Journal of Internal Medicine.2017; 32(4): 600.     CrossRef
Genetic deficiency of Wnt5a diminishes disease severity in a murine model of rheumatoid arthritis
Susan MacLauchlan, Maria A. Zuriaga, José J. Fuster, Carla M. Cuda, Jennifer Jonason, Fernanda Behzadi, Jennifer Parker Duffen, G. Kenneth Haines, Tamar Aprahamian, Harris Perlman, Kenneth Walsh
Arthritis Research & Therapy.2017;[Epub]     CrossRef
Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib
Maria M. Posada, Ellen A. Cannady, Christopher D. Payne, Xin Zhang, James A. Bacon, Y. Anne Pak, J. William Higgins, Nazila Shahri, Stephen D. Hall, Kathleen M. Hillgren
Clinical and Translational Science.2017; 10(6): 509.     CrossRef
Reactive oxygen species mediated NF-κB/p38 feedback loop implicated in proliferation inhibition of HFLS-RA cells induced by 1,7-dihydroxy-3,4-dimethoxyxanthone
Jian Zuo, De-Yu Dou, Hui-Fang Wang, Yan-Hong Zhu, Yan Li, Jia-Jie Luan
Biomedicine & Pharmacotherapy.2017; 94: 1002.     CrossRef
Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study
Shafay Raheel, Eric L. Matteson, Cynthia S. Crowson, Elena Myasoedova
Rheumatology.2017; 56(12): 2154.     CrossRef
RhoB blockade selectively inhibits autoantibody production in autoimmune models of rheumatoid arthritis and lupus
Laura Mandik-Nayak, James B. DuHadaway, Jennifer Mulgrew, Elizabeth Pigott, Kaylend Manley, Summer Sedano, George C. Prendergast, Lisa D. Laury-Kleintop
Disease Models & Mechanisms.2017;[Epub]     CrossRef
Protective effect of kaempferol, a flavonoid widely present in varieties of edible plants, on IL-1β-induced inflammatory response via inhibiting MAPK, Akt, and NF-κB signalling in SW982 cells
Jun-Jiang Lian, Bin-Feng Cheng, Yao-Xin Gao, Han Xue, Lei Wang, Mian Wang, Hai-Jie Yang, Zhi-Wei Feng
Journal of Functional Foods.2016; 27: 214.     CrossRef
Understanding the diverse functions of Huatan Tongluo Fang on rheumatoid arthritis from a pharmacological perspective
CHUNSONG ZHENG, MINGSHAN QIU, XIAOJIE XU, HONGZHI YE, QIAN ZHANG, YIHAN LI, XIANXIANG LIU, JINCHUN CHEN
Experimental and Therapeutic Medicine.2016; 12(1): 87.     CrossRef
Intraarticular Administration of Dobesilate for the Treatment of Knee Rheumatoid Arthritis
Pedro Cuevas
MOJ Clinical & Medical Case Reports.2016;[Epub]     CrossRef